January 3, 2013
The Leukemia & Lymphoma Society (LLS) is sponsoring and issuing this Request for Applications (RFA) from qualified academic laboratories for drug discovery support specifically directed towards medicinal chemistry and/or drug target screening in hematological malignancies.
LLS recognizes a significant need for investigators to receive resources for high-throughput screening and optimization of small molecules into drug-like compounds suitable for in vivo testing in a disease-relevant model that can be used for further preclinical proof-of-concept testing of the new drug target.
Up to six laboratories/projects will be selected during the first year to participate in this new model of collaboration whereby LLS, grantee, sponsoring institutions, investigators and appropriate service providers such as contract research organizations ("CRO") or core facilities at academic institutions, work together to develop compounds with the potential to change the standard of care for patients with blood cancer.